Clinical trial
Prospective Paired Study on the Effectiveness of MitoGrade
NCT02673125 is registered in ClinicalTrials.gov with Reprogenetics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Paired Study on the Effectiveness of MitoGrade
- Lead sponsor
- Reprogenetics
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- January 31, 2017
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.